SentreHEART
Achieving seamless soft tissue closure with innovative remote suture technology, without leaving any metal, clips, or fabrics behind.
Achieving seamless soft tissue closure with innovative remote suture technology, without leaving any metal, clips, or fabrics behind.
SentreHEART, Inc. is a medical device company based in Redwood City, California, established in 2005. The company specializes in producing the LARIAT Suture Delivery Device, which utilizes innovative remote suture technology for seamless soft tissue closure. This technology enables the remote deployment of a 40mm pre-tied suture loop through an access point as small as 4.3mm, without leaving any metal, clips, or fabrics behind. SentreHEART has obtained regulatory approval for soft tissue ligation and approximation in the US, Europe, and Canada. Notably, SentreHEART received a significant $35.00M Series D investment on September 27, 2016. The investors involved in this round were Prospect Venture Partners, US Venture Partners, Vivo Capital, Decheng Capital, and Deerfield. This investment further reflects the confidence and support the company has garnered from prominent venture capital firms, highlighting the potential and promising future of SentreHEART in the Health Care and Medical Devices industries.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series D | $35.00M | 5 |
|
27 Sep 2016 |
| Series C | $26.00M | 3 |
|
04 Jun 2012 |
| Series B | $5.99M | - | 16 Jan 2007 | |
| Series A | $2.03M | - | 17 Aug 2005 |
No recent news or press coverage available for SentreHEART.
We care about your data, and we'd love to use cookies make your experience better.
